Subcutaneous infusion/injection port needle
United Kingdom·General Medical Device·Shire Human Genetic Therapies, Inc. (Shire HGT)·Registered Nov 26, 2024- Device ID
- 102093
- MHRA Reference Number
- 102093
- Date Registered
- Nov 26, 2024
- Last Updated
- Jul 27, 2024
- Device Type
- General Medical Device
- Devices
- Subcutaneous infusion/injection port needle
- Type
- Class IIa
- Address
- 300 Shire Way Lexington, MA, United States
- Created Date
- Sep 1, 2021
- Relationship Type
- UK Responsible Person
- Address
- Beaver House, 23-38 Hythe Bridge Street Oxford, England, United KingdomPostcode: OX1 2EP
Devices with a matching generic name or device type registered with MHRA
Additional devices registered by the same manufacturer
Additional devices represented by MT Promedt Consulting Ltd in the UK
Subcutaneous infusion/injection port needle is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 102093. The device is manufactured by Shire Human Genetic Therapies, Inc. (Shire HGT) from United States, classified as General Medical Device. The authorized representative in the UK is MT Promedt Consulting Ltd.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.